School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Incannex Healthcare Inc. IXHL

Healthcare · Drug Manufacturers - Specialty & Generic

$3.10last close 2026-10-09 · market cap $38.89M · delayed data

Trailing returns

1M-4.02%
3M-8.01%
6M+7.64%
1Y-75.40%

Basis: Adjusted daily closes.

What it does

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Open IXHL in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies